Sandbox:Nuha: Difference between revisions
Jump to navigation
Jump to search
Replaced content with "<br /> =='''Table 1. Risk Score For Drug-Associated QTc Prolongation'''== {| class="wikitable sortable mw-collapsible" style="border: 0px; font-size: 90%; margin: 3px;" al..." Tags: Replaced Visual edit |
|||
Line 1: | Line 1: | ||
<br /> | <br /> | ||
=='''Table 1. Risk Score For Drug-Associated QTc Prolongation'''== | =='''Table 1. Risk Score For Drug-Associated QTc Prolongation'''== | ||
{| class="wikitable | {| class="wikitable" style="border: 0px; font-size: 90%; margin: 3px;" align="center" | ||
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |'''Risk Factors''' | ! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |'''Risk Factors''' | ||
! colspan="1" style="background: #4479BA; padding: 5px 5px;" |'''Points''' | ! colspan="1" style="background: #4479BA; padding: 5px 5px;" |'''Points''' | ||
Line 44: | Line 44: | ||
|K+ indicates potassium; and MI, myocardial infarction. | |K+ indicates potassium; and MI, myocardial infarction. | ||
| | | | ||
|}__NOTOC__<br /> | |}__NOTOC__ | ||
A Tisdale score of ≤ 6 predicts low risk, 7-10 medium risk, and ≥ 11 high risk of drug-associated QT prolongation (Table 2). | |||
{| class="wikitable" | |||
!'''Table 2. Risk Levels For Drug-Associated QT Prolongation''' | |||
|- | |||
|Low risk = ≤6 points | |||
|- | |||
|Moderate risk = 7-10 points | |||
|- | |||
|High-risk = ≥11 points | |||
|} | |||
<br /> |
Revision as of 01:15, 30 June 2020
Table 1. Risk Score For Drug-Associated QTc Prolongation
Risk Factors | Points |
---|---|
Age ≥68 y
|
1
|
Female sex | 1 |
Loop diuretic | 1 |
Serum K+ ≤3.5 mEq/L | 2 |
Admission QTc ≥450 ms | 2 |
Acute MI | 2 |
≥2 QTc-prolonging drugs | 3 |
sepsis | 3 |
Heart failure | 3 |
One QTc-prolonging drug | 3 |
Maximum Risk Score | 21 |
K+ indicates potassium; and MI, myocardial infarction. |
A Tisdale score of ≤ 6 predicts low risk, 7-10 medium risk, and ≥ 11 high risk of drug-associated QT prolongation (Table 2).
Table 2. Risk Levels For Drug-Associated QT Prolongation |
---|
Low risk = ≤6 points |
Moderate risk = 7-10 points |
High-risk = ≥11 points |